pharma industry

CSPC delivered lower nine-month revenues and profits

CSPC feels the pain from sweeping cuts in drug prices

The pharmaceutical giant is paying the price for its aggressively low bids in China’s centralized drug tenders, as it shifts its focus from traditional to novel drugs Key Takeaway: The…
1093.HK
Illustration of China stock price in a see-saw pattern

CHINA BULLETIN: Mixed Messages in July PMI

In this week’s issue mixed PMI messages, a new data regulator and a coffee rebound. On a scale of 1 to 100, we give the week a 55 for offshore-listed China stocks.

Recent Articles

RELATED ARTICLES

  1. CSPC Pharma teases big bucks deals after earnings miss
    CSPC Pharma teases big bucks deals after earnings miss
    1093.HK
  2. Precision cancer drugs show promise for Kelun-Biotech
    6990.HK
  3. Alphamab stake sale could signal harder times ahead
    9966.HK
  4. XtalPi scores landmark deal for AI drug discovery
    2228.HK
  5. Rising profit at WuXi Biologics underscores drug sector rebound
    2269.HK
  6. ​​Medtide launches IPO to bulk up its weight-loss business
    3880.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva